Judge Andrew Napolitano, a senior judicial analyst for Fox News, agreed with the Department of Justice that with the settlement, the deal doesn’t raise any antitrust concerns.
“It does not violate the antitrust laws, it’s horizontal. It does not impede competition, it enhances competition. It lowers prices,” Mr. Napolitano told Fox Business April 8. “It’s the type of merger that a judge should approve in a heartbeat.”
The statement comes after the federal judge reviewing the agreement said he wants to hold a hearing for opponents of the deal. While Aetna agreed to sell its Medicare Part D prescription drug plan to merge with CVS, Judge Richard Leon was not as convinced that the department’s agreement alleviated antitrust concerns.
Mr. Leon said he plans to listen to critics of the deal in May. The American Medical Association, AIDS Healthcare Foundation, and other pharmacy and consumer groups have spoken out against the deal.
More articles on payers:
BCBS of Texas to open primary care clinics: 5 things to know
128,000 kids lost health insurance in Tennessee over 2 years — Here’s why
Pennsylvania woman denied coverage for sepsis-related foot amputation
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
